首页> 外文期刊>Nucleic Acids Research >OneD: increasing reproducibility of Hi-C samples with abnormal karyotypes
【24h】

OneD: increasing reproducibility of Hi-C samples with abnormal karyotypes

机译:ONED:提高Hi-C样品的再现性,核型异常

获取原文
获取原文并翻译 | 示例
           

摘要

The three-dimensional conformation of genomes is an essential component of their biological activity. The advent of the Hi-C technology enabled an unprecedented progress in our understanding of genome structures. However. Hi-C is subject to systematic biases that can compromise downstream analyses. Several strategies have been proposed to remove those biases, but the issue of abnormal karyotypes received little attention. Many experiments are performed in cancer cell lines, which typically harbor large-scale copy number variations that create visible defects on the raw Hi-C maps. The consequences of these widespread artifacts on the normalized maps are mostly unexplored. We observed that current normalization methods are not robust to the presence of large-scale copy number variations, potentially obscuring biological differences and enhancing batch effects. To address this issue, we developed an alternative approach designed to take into account chromosomal abnormalities. The method, called OneD, increases reproducibility among replicates of Hi-C samples with abnormal karyotype, outperforming previous methods significantly. On normal karyotypes, OneD fared equally well as state-of-the-art methods, making it a safe choice for Hi-C normalization. OneD is fast and scales well in terms of computing resources for resolutions up to 5kb.
机译:基因组的三维构象是其生物活性的基本组分。在我们对基因组结构的理解中,Hi-C技术的出现使得前所未有的进展。然而。 Hi-C受系统偏差,可以危及下游分析。已经提出了几种策略来消除这些偏见,但异常核型的问题几乎没有注意。许多实验是在癌症细胞系中进行的,这通常是含有大规模拷贝数变异,在原始的Hi-C地图上产生可见的缺陷。这些广泛文物对归一化地图的后果主要是未开发的。我们观察到,目前的归一化方法对存在大规模拷贝数变异的存在并不稳健,可能模糊生物差异和增强批量效应。为了解决这个问题,我们开发了一种旨在考虑染色体异常的替代方法。调用ONED的方法增加了高-C样品复制的再现性,具有异常的核型,显着优于先前的方法。在正常的核型内,同样良好的核心型,作为最先进的方法,使其成为Hi-C标准化的安全选择。在计算资源方面,在计算资源方面的分辨率高达5KB的资源,oned快速衡量。

著录项

  • 来源
    《Nucleic Acids Research》 |2018年第8期|共10页
  • 作者单位

    BIST Ctr Genom Regulat CRG Gene Regulat Stem Cells &

    Canc Program Dr Aiguader 88 Barcelona 08003 Spain;

    BIST Ctr Genom Regulat CRG Gene Regulat Stem Cells &

    Canc Program Dr Aiguader 88 Barcelona 08003 Spain;

    BIST Ctr Genom Regulat CRG Gene Regulat Stem Cells &

    Canc Program Dr Aiguader 88 Barcelona 08003 Spain;

    BIST Ctr Genom Regulat CRG Gene Regulat Stem Cells &

    Canc Program Dr Aiguader 88 Barcelona 08003 Spain;

    BIST Ctr Genom Regulat CRG Gene Regulat Stem Cells &

    Canc Program Dr Aiguader 88 Barcelona 08003 Spain;

    BIST Ctr Genom Regulat CRG Gene Regulat Stem Cells &

    Canc Program Dr Aiguader 88 Barcelona 08003 Spain;

    BIST Ctr Genom Regulat CRG Gene Regulat Stem Cells &

    Canc Program Dr Aiguader 88 Barcelona 08003 Spain;

    BIST Ctr Genom Regulat CRG Gene Regulat Stem Cells &

    Canc Program Dr Aiguader 88 Barcelona 08003 Spain;

    BIST Ctr Genom Regulat CRG Gene Regulat Stem Cells &

    Canc Program Dr Aiguader 88 Barcelona 08003 Spain;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号